633327-49-8 Usage
General Description
N-(5-Fluoro-2-methyl-4-nitrophenyl)acetamide is a chemical compound with the molecular formula C9H9FN2O3. It is an acetamide derivative that contains a fluorine atom, a methyl group, and a nitro group attached to a phenyl ring. N-(5-Fluoro-2-methyl-4-nitrophenyl)acetamide is commonly used in the field of pharmaceutical research and development, particularly in the synthesis of potential drug candidates. Its diverse chemical structure makes it a valuable intermediate in the creation of new molecules with potential medical applications. Additionally, the fluoro and nitro groups in its structure can also impart specific biological activities and properties to the synthesized compounds, contributing to the development of new pharmaceuticals.
Check Digit Verification of cas no
The CAS Registry Mumber 633327-49-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,3,3,3,2 and 7 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 633327-49:
(8*6)+(7*3)+(6*3)+(5*3)+(4*2)+(3*7)+(2*4)+(1*9)=148
148 % 10 = 8
So 633327-49-8 is a valid CAS Registry Number.
InChI:InChI=1/C9H9FN2O3/c1-5-3-9(12(14)15)7(10)4-8(5)11-6(2)13/h3-4H,1-2H3,(H,11,13)
633327-49-8Relevant articles and documents
BENZIMIDAZOLE DERIVATIVES
-
Page/Page column 53; 81, (2021/06/26)
The invention relates to benzimidazoles of Formula (I) and pharmaceutically acceptable salts thereof, wherein R1 to R6 are as defined in the description; to their use in medicine; to compositions containing them; to processes for their preparation; and to intermediates used in such processes. The benzimidazoles of Formula (I) are ITK inhibitors and are therefore potentially useful in the treatment of a wide range of disorders including, atopic dermatitis.
BENZIMIDAZOLE DERIVATIVES AS SELECTIVE PROTEINE KINASE INHIBITORS
-
Page/Page column 56-57, (2015/01/07)
The present invention relates to compounds of formula (I) or pharmaceutically acceptable salts thereof. Wherein n, R1, R2, R3, R4, R5, A, Q and X are as defined in the description. These compounds selectively modulate, regulate, and/or inhibit signal transduction mediated by certain native and/or mutant proteine kinases implicated in a variety of human and animal diseases such as cell proliferative, metabolic, allergic, and degenerative disorders. More particularly, these compounds are potent and selective native and/or mutant c-kit inhibitors.
